VU University Medical Centre
Welcome,         Profile    Billing    Logout  
 18 Trials 
18 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Senan, Suresh
SABR-COMET 10, NCT03721341: Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors

Active, not recruiting
3
204
Europe, Canada, RoW
Palliative Radiation, Palliative Radiotherapy, Chemotherapy, Immunotherapy, Hormones, Observation, Stereotactic Ablative Radiotherapy
David Palma, Amsterdam University Medical Centre, VUmc Site, British Columbia Cancer - Centre for the North, Beaston West of Scotland Cancer Centre, London Health Sciences Centre
Metastatic Tumors
01/29
01/29
SABR-COMET, NCT01446744: Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Tumors

Active, not recruiting
2
99
Europe, Canada, RoW
Stereotactic ablative radiotherapy, palliative radiotherapy
Lawson Health Research Institute, London Regional Cancer Program, Canada, VU University of Amsterdam
Metastatic Tumors
06/26
06/26
FAST-METS, NCT05288608: Evaluation of Fast, Same-day Delivery of Palliative Radiotherapy Without a Planning CT

Recruiting
N/A
60
Europe
Amsterdam UMC, location VUmc
Metastasis
12/22
03/23
HAMLET, NCT02488850: Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC

Completed
N/A
32
Europe
Surgery, SABR
Erasmus Medical Center
Non-small Cell Lung Cancer
04/22
04/22
Berckel, Bart van
COVFATI, NCT05371522: Neuro-inflammation and Post-infectious Fatigue in Individuals With and Without COVID-19

Enrolling by invitation
2/3
30
Europe
[18F]DPA-714 positron emission tomography (PET) scan
Amsterdam UMC, location VUmc, ZonMw: The Netherlands Organisation for Health Research and Development
COVID-19
09/23
09/23
Nanayakkara, Prabath
BIOSEP, NCT06178822: Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room

Recruiting
N/A
3300
Europe
No intervention
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC), Amsterdam UMC, location VUmc, Flevoziekenhuis
Sepsis, Septic Shock, Sepsis, Severe, Infections, Infection Viral, Infection, Bacterial, Infections, Respiratory
10/26
10/26
ABC, NCT06163781: Appropriate Use of Blood Cultures in the Emergency Department Through Machine Learning

Recruiting
N/A
7584
Europe
Blood culture prediction tool
Amsterdam UMC, location VUmc
Artificial Intelligence, Machine Learning, Microbiology, Emergency Service, Hospital, Randomized Controlled Trial
01/27
07/27
Verheul, Henk MW
SUNRISE-CRC, NCT03909724: Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC)

Recruiting
2/3
60
Europe
Sunitinib Malate, Sutent, TAS 102, Lonsurf
Amsterdam UMC, location VUmc
Colorectal Cancer, Metastasis
07/21
07/22
CAIRO6, NCT02758951 / 2016-001865-99: Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

Active, not recruiting
2/3
358
Europe
Perioperative systemic therapy, Perioperative CAPOX-bevacizumab, Perioperative FOLFOX-bevacizumab, Perioperative FOLFIRI-bevacizumab, CRS-HIPEC, experimental arm, CRS-HIPEC, control arm
Koen Rovers, Dutch Cancer Society, Comprehensive Cancer Centre The Netherlands, Hoffmann-La Roche
Colorectal Neoplasm, Colorectal Cancer, Colorectal Neoplasms Malignant, Colorectal Carcinoma, Colorectal Adenocarcinoma, Peritoneal Neoplasms, Peritoneal Carcinomatosis, Peritoneal Cancer, Peritoneal Metastases, Peritoneal Neoplasm Malignant Secondary Carcinomatosis, Peritoneal Neoplasm Malignant Secondary
10/24
06/29
eNRGy, NCT02912949 / 2014-003277-42: A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion

Active, not recruiting
2
250
Europe, Canada, Japan, US, RoW
zenocutuzumab (MCLA-128), bispecific, MCLA-128
Merus N.V.
Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
12/26
12/26
NCT04954599 / 2021-000423-12: Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Recruiting
1/2
126
Europe
CP-506, HAP CP-506, Carboplatin, Paraplatin, Immune checkpoint inhibitor, Ipilimumab, Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab, Cemiplimab
Maastricht University Medical Center, Erasmus Medical Center, Jules Bordet Institute, Academisch Ziekenhuis Maastricht
Unspecified Adult Solid Tumor, Protocol Specific
02/26
05/26
Hemmer, Patrick H
COLOPEC-II, NCT03413254: Second and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of Peritoneal Metastases

Active, not recruiting
3
389
Europe
Routine follow-up, Second look DLS, Third look DLS
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Colorectal Cancer, Peritoneal Metastases
03/25
10/28
CAIRO6, NCT02758951 / 2016-001865-99: Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

Active, not recruiting
2/3
358
Europe
Perioperative systemic therapy, Perioperative CAPOX-bevacizumab, Perioperative FOLFOX-bevacizumab, Perioperative FOLFIRI-bevacizumab, CRS-HIPEC, experimental arm, CRS-HIPEC, control arm
Koen Rovers, Dutch Cancer Society, Comprehensive Cancer Centre The Netherlands, Hoffmann-La Roche
Colorectal Neoplasm, Colorectal Cancer, Colorectal Neoplasms Malignant, Colorectal Carcinoma, Colorectal Adenocarcinoma, Peritoneal Neoplasms, Peritoneal Carcinomatosis, Peritoneal Cancer, Peritoneal Metastases, Peritoneal Neoplasm Malignant Secondary Carcinomatosis, Peritoneal Neoplasm Malignant Secondary
10/24
06/29
Tuynman, Jurriaan B
COLORIII, NCT02736942: COLOR III Trial: Transanal vs Laparoscopic TME

Enrolling by invitation
3
1104
Europe
Laparoscopic TME, TaTME
Amsterdam UMC, location VUmc
Rectal Carcinoma, Surgery
05/21
05/25
COLOPEC-II, NCT03413254: Second and Third Look Laparoscopy in pT4 Colon Cancer Patients for Early Detection of Peritoneal Metastases

Active, not recruiting
3
389
Europe
Routine follow-up, Second look DLS, Third look DLS
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Colorectal Cancer, Peritoneal Metastases
03/25
10/28
CAIRO6, NCT02758951 / 2016-001865-99: Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

Active, not recruiting
2/3
358
Europe
Perioperative systemic therapy, Perioperative CAPOX-bevacizumab, Perioperative FOLFOX-bevacizumab, Perioperative FOLFIRI-bevacizumab, CRS-HIPEC, experimental arm, CRS-HIPEC, control arm
Koen Rovers, Dutch Cancer Society, Comprehensive Cancer Centre The Netherlands, Hoffmann-La Roche
Colorectal Neoplasm, Colorectal Cancer, Colorectal Neoplasms Malignant, Colorectal Carcinoma, Colorectal Adenocarcinoma, Peritoneal Neoplasms, Peritoneal Carcinomatosis, Peritoneal Cancer, Peritoneal Metastases, Peritoneal Neoplasm Malignant Secondary Carcinomatosis, Peritoneal Neoplasm Malignant Secondary
10/24
06/29
NCT03426397: "Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer

Recruiting
N/A
220
Europe
The Netherlands Cancer Institute, Dutch Cancer Society
Rectal Neoplasms
06/21
06/26
NCT04889456: Standardizing Right Hemicolectomy for Colon Cancer

Not yet recruiting
N/A
930
Europe
Implementation standardised laparoscopic right hemicolectomy with proctoring, Implementation standardised laparoscopic right hemicolectomy without proctoring
VU University Medical Center, Prof. dr. P.J. Tanis, colorectal surgeon, Dr. B.R. Toorenvliet, colorectal surgeon, D. Miskovic, St Marks hospital London, UK, S. Benz, Klinikverbund SuedWest, Böblingen, Germany, F. Aigner, Krankenhaus der Barmherzigen Bruder, Graz, Austria, C.A. Bertelsen, Hillerød University Hospital, Copenhagen, Denmark, Drs. A.A.J. Grüter, Dr. U.K. Coblijn, Dr. H.L. van Westreenen, Dr. C. Sietses, Prof. dr. E.C.J. Consten, Dr. A.W.H. van de Ven, Dr. P. van Duijvendijk, Dr. S. van Aalten, Dr. F. den Boer, Dr. J.W.A. Leijtens, Dr. C. Hoff, Dr. O. van Ruler, Dr. G. D. Slooter, Prof. dr. J. Lange, Prof. dr. G.J. Kleinrensink
Colonic Carcinoma, Laparoscopic Right Hemicolectomy, Standardisation, Training, Delphi Study, Implementation, Consolidation, Assessment
07/22
07/27
Voskuyl, A
No trials found

Download Options